Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NIC002 Vaccine in Nicotine Dependence
NCT01280968Phase 2Completed
- Start
- Dec 2010
- Primary completion
- Sep 2012
- Modality
- Therapeutic Vaccines, Recombinant Protein Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of NIC002 in nicotine dependence. Started Dec 2010; status: completed.
02
Drugs
NIC002
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT01280968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01280968.